248 related articles for article (PubMed ID: 9135154)
1. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.
Komarova EA; Chernov MV; Franks R; Wang K; Armin G; Zelnick CR; Chin DM; Bacus SS; Stark GR; Gudkov AV
EMBO J; 1997 Mar; 16(6):1391-400. PubMed ID: 9135154
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.
Gottlieb E; Haffner R; King A; Asher G; Gruss P; Lonai P; Oren M
EMBO J; 1997 Mar; 16(6):1381-90. PubMed ID: 9135153
[TBL] [Abstract][Full Text] [Related]
3. p53 deficiency alters the yield and spectrum of radiation-induced lacZ mutants in the brain of transgenic mice.
Chang PY; Kanazawa N; Lutze-Mann L; Winegar RA
Mutagenesis; 2001 Jan; 16(1):7-15. PubMed ID: 11139594
[TBL] [Abstract][Full Text] [Related]
4. Different impact of p53 and p21 on the radiation response of mouse tissues.
Komarova EA; Christov K; Faerman AI; Gudkov AV
Oncogene; 2000 Aug; 19(33):3791-8. PubMed ID: 10949934
[TBL] [Abstract][Full Text] [Related]
5. Age-related mutation accumulation at a lacZ reporter locus in normal and tumor tissues of Trp53-deficient mice.
Giese H; Snyder WK; van Oostrom C; van Steeg H; Dollé ME; Vijg J
Mutat Res; 2002 Feb; 514(1-2):153-63. PubMed ID: 11815254
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse model reveals humanlike regulation of an 8-kbp human TERT gene promoter fragment in normal and tumor tissues.
Ritz JM; Kühle O; Riethdorf S; Sipos B; Deppert W; Englert C; Günes C
Cancer Res; 2005 Feb; 65(4):1187-96. PubMed ID: 15735002
[TBL] [Abstract][Full Text] [Related]
7. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
8. The p53 response to ionising radiation in adult and developing murine tissues.
MacCallum DE; Hupp TR; Midgley CA; Stuart D; Campbell SJ; Harper A; Walsh FS; Wright EG; Balmain A; Lane DP; Hall PA
Oncogene; 1996 Dec; 13(12):2575-87. PubMed ID: 9000131
[TBL] [Abstract][Full Text] [Related]
9. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
10. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific induction of p53 targets in vivo.
Fei P; Bernhard EJ; El-Deiry WS
Cancer Res; 2002 Dec; 62(24):7316-27. PubMed ID: 12499275
[TBL] [Abstract][Full Text] [Related]
12. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
[TBL] [Abstract][Full Text] [Related]
13. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
14. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
15. Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.
Itamochi H; Yamasaki F; Sudo T; Takahashi T; Bartholomeusz C; Das S; Terakawa N; Ueno NT
Cancer Gene Ther; 2006 May; 13(5):451-9. PubMed ID: 16294215
[TBL] [Abstract][Full Text] [Related]
16. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
[TBL] [Abstract][Full Text] [Related]
17. Transient expression of tyrosine hydroxylase promoter/reporter gene constructs in the olfactory epithelium of transgenic mice.
Sasaki H; Berlin R; Baker H
J Neurocytol; 2004 Dec; 33(6):681-92. PubMed ID: 16217623
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene.
Lee Y; Su M; Messing A; Brenner M
Glia; 2006 May; 53(7):677-87. PubMed ID: 16482522
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
